Business
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients, today announced that it has named Aranthan \"AJ\" Jones II as its Chief Corporate Affairs and Communications Officer and Joakim \"Kim\" Wijkstrom as its Chief Marketing Officer. Mr. Jones II and Mr. Wijkstrom will report directly to Mihael H. Polymeropoulos, M.D., Vanda's President and CEO. \n\"I am very pleased to welcome both AJ and Kim to Vanda's executive leadership team,\" said Dr. Polymeropoulos. \"They are both exceptional leaders in their respective fields and bring a wealth of expertise that we believe will be instrumental to the execution of our global strategy.\" \nPrior to joining Vanda, Mr. Jones II served as Global Head of Public Affairs for Burson Cohn & Wolfe (BCW) where he counseled Fortune 500 clients on corporate affairs and communications, investor relations, government relations, public policy and social impact initiatives. Prior to this position, Mr. Jones II was a senior executive at the W.K. Kellogg Foundation, one the world's largest private philanthropic foundations, and was formally the Worldwide Head of Government Affairs for Gilead Sciences. \nMr. Wijkstrom has held Chief Marketing Officer positions at Perry Ellis and One Main Financial. Additionally, Mr. Wijkstrom served in senior leadership positions with award winning advertising agencies: TBWA Chiat Day, BBDO and CP+B, where he led holistic marketing campaigns for a number of well-known companies.\nAbout Vanda Pharmaceuticals Inc.Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.\nForward Looking StatementsVarious statements in this release are \"forward-looking statements\" under the securities laws. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include the ability of ...